NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-265-2011-0-JP-09 Anti-CD22 Chimeric Antigen Receptors JP National Stage 2014-537287 Abandoned
NCI E-265-2011-0-CN-06 Anti-CD22 Chimeric Antigen Receptors CN National Stage 201280051365.6 Abandoned
NHLBI E-051-2019-0-CN-04 Methods and systems for automatically determining magnetic field inversion time of a tissue species CN ORD 201410154479.4 Abandoned
NCI E-265-2011-0-US-11 Anti-CD22 Chimeric Antigen Receptors US National Stage 14/352,530 9868774 Issued PDF
NCI E-265-2011-0-NL-22 Anti-CD22 Chimeric Antigen Receptors NL EP 12781544.7 Abandoned
NCI E-265-2011-0-ES-19 Anti-CD22 Chimeric Antigen Receptors ES EP 12781544.7 Abandoned
NCI E-265-2011-0-GB-17 Anti-CD22 Chimeric Antigen Receptors GB EP 12781544.7 Abandoned
NCI E-265-2011-0-CH-18 Anti-CD22 Chimeric Antigen Receptors CH EP 12781544.7 Abandoned
NCI E-265-2011-0-FR-16 Anti-CD22 Chimeric Antigen Receptors FR EP 12781544.7 Abandoned
NCI E-265-2011-0-DE-15 Anti-CD22 Chimeric Antigen Receptors DE EP 12781544.7 Abandoned
NCI E-265-2011-0-LI-21 Anti-CD22 Chimeric Antigen Receptors LI EP 12781544.7 Abandoned
NCI E-265-2011-0-IT-20 Anti-CD22 Chimeric Antigen Receptors IT EP 12781544.7 Abandoned
NEI E-769-2013-0-PCT-02 COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING MACULAR DEGENERATION PCT PCT PCT/US2014/034538 Expired
NHLBI E-051-2019-0-KR-03 METHODS AND SYSTEMS FOR AUTOMATICALLY DETERMINING MAGNETIC FIELD INVERSION TIME OF A TISSUE SPECIES KR ORD 10-2014-0124733 Abandoned
NCI E-220-2011-0-US-06 HYBRID DIAZENIUMDIOLATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHOD OF TREATING CANCER US National Stage 14/352,096 9168266 Issued PDF
NCI E-212-2011-0-US-03 Monospecific And Bispecific Human Monoclonal Antibodies Targeting Insulin-Like Growth Factor II (IGF-II) US National Stage 14/352,312 9127056 Abandoned PDF
NCI E-074-2007-0-JP-15 BRACHYURY POLYPEPTIDES AND METHODS OF USE JP DIV 2014-083444 Issued
NIA E-092-2011-0-JP-07 The Use Of (2R,6R)-hydroxynorketamine, (S)-dehydronorketamine And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain JP National Stage 2014-535975 Issued
NCI E-220-2011-0-GB-09 HYBRID DIAZENIUMDIOLATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHOD OF TREATING CANCER GB EP 12841601.3 Issued
NCI E-220-2011-0-FR-08 HYBRID DIAZENIUMDIOLATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHOD OF TREATING CANCER FR EP 12841601.3 Issued
NCI E-220-2011-0-DE-07 HYBRID DIAZENIUMDIOLATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHOD OF TREATING CANCER DE EP 12841601.3 Issued
NEI E-169-2008-0-US-07 Methods of Using Interferon Gamma to Absorb Fluid from the Subretinal Space US CON 14/252,489 9486502 Issued PDF
NCI E-024-2009-0-US-09 Gene Signature For Predicting Prognosis Of Patients With Solid Tumors US DIV 14/252,005 9394358 Issued PDF
NIA E-092-2011-0-US-08 THE USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)- KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN US National Stage 14/351,441 9650352 Issued PDF
NCI E-265-2011-0-BR-04 Anti-CD22 Chimeric Antigen Receptors BR National Stage BR112014008849-7 Abandoned
NIA E-092-2011-0-CA-04 THE USE OF HYDROXYNORKETAMINE, DEHYDRONORKETAMINE AND OTHER KETAMINE METABOLITES IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN CA National Stage 2851619 Issued
NIAAA E-060-2010-0-CA-07 Hydroxybutyrate Ester And Medical Use Thereof CA National Stage 2734720 Issued
NCATS E-234-2012-0-PH-22 PAK Inhibitors For the Treatment of Fragile X Syndrome PH National Stage 1-2014-500956 Pending
NCI E-139-2007-0-US-10 Methods And Compositions For Detecting Immune Responses US DIV 14/247,372 Abandoned
NCATS E-287-2011-0-RU-14 Amido Compounds As RORgt Modulators And Uses Thereof RU National Stage 2014113926 Abandoned
NIAID E-153-2015-0-US-01 Antiviral Compounds Effective Against SARS and MERS Coronavirus US 61/976,031 Abandoned
NCI E-116-2014-0-US-01 Iodonium Analogs As Inhibitors Of NADPH Oxidases And Other Flavin Dehydrogenases; Formulations Thereof; And Uses Thereof US 61/976,362 Abandoned
NHLBI E-051-2019-0-US-02 Improved Image Contrast In Inversion MfR Imaging, Improved Workflow And Inter-scan Reliabilibity In MRI Myocardial Viability Imaging US ORD 14/245,011 9734573 Issued PDF
NCI E-227-2006-5-AU-09 PREVENTION OF TISSUE ISCHEMIA, RELATED METHODS AND COMPOSITIONS AU DIV 2014201936 Issued
NIAID E-189-2011-2-CN-02 Treatment And Prevention Of Diseases Mediated By Microorganisms via Drug-Mediated Manipulation of the Eicosanoid Balance CN National Stage 201280049137.5 Abandoned
NCATS E-287-2011-0-BR-04 Amido Compounds As RORgt Modulators And Uses Thereof BR National Stage BR112014005268-9 Abandoned
NCI E-109-2014-0-US-01 Use of GTF2I Mutations in the Prognosis of Thymic Cancers US 61/975,222 Abandoned
NCI E-192-2008-1-US-04 Expression of IL-12 Family Heterodimers US DIV 14/244,768 9546202 Issued PDF
NCI E-217-2011-0-US-03 Genetic Marker For Predicting Prognosis In Patients Infected With Hepatitis C Virus US National Stage 14/349,395 Abandoned
NIDDK E-284-2008-0-US-10 Low Molecular Weight Thyroid Stimulating Hormone Receptor (TSHR) Agonists US CON 14/243,821 9296729 Issued PDF
NHGRI E-116-2011-0-US-04 Method of Treating Pathologic Heterotopic Ossification US National Stage 14/130,220 Abandoned
NCI E-065-2014-0-US-01 Use Of RNA Splicing Inhibitors To Overcome Drug Resistance US 61/974,378 Abandoned
NCI E-080-2014-0-US-01 ZIRCONIUM-89 OXINE COMPLEX AS A CELL LABELING AGENT FOR POSITRON EMISSION TOMOGRAPHY US 61/973,706 Abandoned
NICHD E-271-2011-0-US-03 Influenza Vaccine US National Stage 14/348,321 Abandoned
NIAMS E-042-2005-0-US-04 Mechanoactive Microfluidic Imaging Bioreactor US CON 14/221,984 Abandoned
NHLBI E-124-2014-0-US-01 Device For Closure Of Transvascular Or Transcameral Access Ports US 61/971,458 Abandoned
NCI E-147-2012-2-US-02 Methods Of Treating Periodontal Inflammation And Periodontal Bone Loss US National Stage 14/347,434 Abandoned
NIAID E-032-2011-0-US-05 Multivalent Vaccines for Rabies Virus and Filoviruses US National Stage 13/983,545 10849975 Issued PDF
NIMH E-156-2006-0-US-05 Beta-amyloid PET Imaging Agents US DIV 14/223,782 Abandoned
NIAID E-293-2011-2-US-06 Novel Influenza Hemagglutinin Protein-Based Vaccines US National Stage 14/346,849 9441019 Issued PDF